Young Age Onset Multivascular Pathology in a Patient with Severe Dyslipidemia: an Incidental Case or a Particular Type of Familial Hypercholesterolemia?

1 Varghese MJ. Familial hypercholesterolemia: A review. Ann Pediatr Cardiol 2014; 7(2):107–117. VargheseMJ Familial hypercholesterolemia: A review Ann Pediatr Cardiol 2014 7 2 107 117 10.4103/0974-2069.132478407019924987256 Search in Google Scholar

2 Hao W, Friedman A. The LDL-HDL profile determines the risk of atherosclerosis: A mathematical model. PLoS One 2014; 9(3):e90497. HaoW FriedmanA The LDL-HDL profile determines the risk of atherosclerosis: A mathematical model PLoS One 2014 9 3 e90497 10.1371/journal.pone.0090497395126424621857 Search in Google Scholar

3 Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 1988; 4(suppl A):5A–10. CastelliWP Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study Can J Cardiol 1988 4 suppl A 5A 10 Search in Google Scholar

4 Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003; 23:1881–88. KontushA ChantepieS ChapmanMJ Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress Arterioscler Thromb Vasc Biol 2003 23 1881 88 10.1161/01.ATV.0000091338.93223.E812920049 Search in Google Scholar

5 Rader DJ. High-density lipoproteins and atherosclerosis. Am J Cardiol 2002; 90:62–70. RaderDJ High-density lipoproteins and atherosclerosis Am J Cardiol 2002 90 62 70 10.1016/S0002-9149(02)02635-8 Search in Google Scholar

6 Francis MC, Frohlich JJ. Coronary artery disease in patients at low risk: Apolipoprotein AI as an independent risk factor. Atherosclerosis 2001; 155:165–70. FrancisMC FrohlichJJ Coronary artery disease in patients at low risk: Apolipoprotein AI as an independent risk factor Atherosclerosis 2001 155 165 70 10.1016/S0021-9150(00)00528-111223438 Search in Google Scholar

7 Leigh SE, Leren TP, Humphries SE. Commentary PCSK9 variants: A new database. Atherosclerosis 2009; 203(1):32–33. LeighSE LerenTP HumphriesSE Commentary PCSK9 variants: A new database Atherosclerosis 2009 203 1 32 33 10.1016/j.atherosclerosis.2009.02.00619249440 Search in Google Scholar

8 Guo Y, Yan B, Gui Y, Tang Z, Tai S, Zhou S et al. Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall. J Cell Physiol 2020; 236(4):2333–51. GuoY YanB GuiY TangZ TaiS ZhouS Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall J Cell Physiol 2020 236 4 2333 51 10.1002/jcp.3002532875580 Search in Google Scholar

9 Pinard A, Jones GT, Milewicz DM. Genetics of thoracic and abdominal aortic diseases. Circ Res 2019; 124(4):588–606. PinardA JonesGT MilewiczDM Genetics of thoracic and abdominal aortic diseases Circ Res 2019 124 4 588 606 10.1161/CIRCRESAHA.118.312436642842230763214 Search in Google Scholar

10 Tanaka H, Inuzuka K, Iida Y, Shimizu H, Unno N, Urano T. Proprotein convertase subtilisin / kexin type 9 is associated with degenerating adipocytes in abdominal aortic aneurysm. J Oleo Sci 2018; 67(10):1355–60. TanakaH InuzukaK IidaY ShimizuH UnnoN UranoT Proprotein convertase subtilisin / kexin type 9 is associated with degenerating adipocytes in abdominal aortic aneurysm J Oleo Sci 2018 67 10 1355 60 10.5650/jos.ess1813130210081 Search in Google Scholar

11 Puntoni M, Sbrana F, Bigazzi F, Sampietro T. Tangier disease: Epidemiology, pathophysiology, and management. Am J Cardiovasc Drugs 2012; 12(5):303–11. PuntoniM SbranaF BigazziF SampietroT Tangier disease: Epidemiology, pathophysiology, and management Am J Cardiovasc Drugs 2012 12 5 303 11 10.1007/BF03261839 Search in Google Scholar

12 Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370:1829–39. Prospective Studies Collaboration LewingtonS WhitlockG ClarkeR SherlikerP EmbersonJ Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths Lancet 2007 370 1829 39 10.1016/S0140-6736(07)61778-418061058 Search in Google Scholar

13 Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM et al. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis. JAMA 2016; 316:1289–97. SilvermanMG FerenceBA ImK WiviottSD GiuglianoRP GrundySM Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis JAMA 2016 316 1289 97 10.1001/jama.2016.1398527673306 Search in Google Scholar